ERDERA Launches the 2025 Joint Transnational Call for Proposals on Rare Disease Therapies 

ERDERA Launches the 2025 Joint Transnational Call for Proposals on Rare Disease Therapies

The European Rare Diseases Research Alliance (ERDERA) is delighted to announce the official launch of its 2025 Joint Transnational Call (JTC) for Proposals as of today, 10 December 2024. This eagerly anticipated call invites research teams across Europe and internationally to collaborate on cutting-edge projects aimed at “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.” 

See all the details of the official call here.  

Application Timeline 

The JTC 2025 will follow a two-stage submission process: 

  • 13 February 2025: Pre-proposal submission deadline. 
  • 9 July 2025: Full proposals submission deadline. Funding decisions are expected by December 2025. 

Interested applicants can join an informational webinar on 17 December 2024, providing valuable guidance on preparing submissions. 

For more information, contact the Joint Call Secretariat at SelteneErkrankungen@dlr.de or reach out to the relevant national contact point. 

Stay informed with the latest updates from ERDERA by subscribing to our newsletter and following us on social media. 

News & Updates

You might also be interested in

ERDERA – the European Rare Diseases Research Alliance – is pleased to announce the upcoming 2nd International Conference on Clinical Research Networks (CRNs) for Rare Diseases, co-organised in collaboration with Rare Disease International and the International Rare Diseases Research Consortium (IRDiRC).
The course will focus on the current status and advancements of clinical research especially to address unmet medical needs. Innovative methodologies, regulatory challenges, and the involvement of adolescents in clinical trials will be discussed.
9–10 December 2025, Heidelberg and online — practical sessions with an agreed delivery to accelerate research